Predicting ICU needs | Accelerating tech solutions | Brain Computer Interface

“It's not that I'm so smart, it's just that I stay with problems longer. — Albert Einstein

Today’s issue:

• Predicting ICU needs
  
• Accelerating tech solutions
  
• Dust
• Cancer & COVID-19
  
• PUDDLE HOPS: Health tech

May 5, 2021

NAVIGATING THE RECOVERY

PANDEMIC INNOVATION

Image by Nhemz for Shutterstock

Predicting deterioration in COVID-19 patients

Data scientists from the Michigan Center for Integrative Research have shown that an analytic model they created is significantly more accurate in predicting deterioration and need for life-saving interventions for COVID-19 positive patients.

Creating tech solutions in Louisville

The University of Louisville has received $750,000 from the U.S. Economic Development Administration to launch a new program aimed at solving the long-term health, economic and societal problems resulting from the COVID-19 pandemic.

Dust

A study out of The Ohio State University shows that the COVID-19 virus's DNA can persist up to a month in dust. They are still in the process of determining whether the dust can transmit the virus to humans.

COVID-19 & cancer

St. Elizabeth Healthcare in Edgewood, KY is an early contributor in a nationwide study that focuses on outcomes for COVID-19 patients with cancer.

Share these stories!

PUDDLE HOPS: HEALTH TECH

Fast Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We're adding coverage to this report related to health care innovation to feature more advances across Fast Future Country. 

• Neurolutions’ IpsiHand System, a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity disability, has received FDA approval.
  

• UC researchers are looking at the connection between a protein found in skeletal muscle fiber and the body’s fight or fight response during stress.

• A clinical trial at The Ohio State University is using gene therapy in a new approach to help those suffering from chronic angina who can’t undergo stenting or coronary bypass surgery.

• Amplified Sciences, a diagnostic cancer testing startup that uses technology created by a Purdue University professor, has received investments from the IU Philanthropic Venture Fund the IU Angel Network.

• Catheter-associated urinary tract infections (CAUTIs) are the second most common healthcare-associated infection in ICUs. A nurse-driven quality improvement at UPMC Williamsport has cut CAUTI rates.

• Indy-based Eli Lilly is seeking first approval of an autoimmune drug for hair loss. The drug, baricitinib, spurred hair regrowth in patients with a severe form of alopecia areata in a second Phase 3 study.

Share these stories!

REACH OUT

Share stories, offer suggestions, or comment!